Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
K
|
Kuehne + Nagel International AG
XMUN:KNIA
|
CH |
|
B
|
Bank Rakyat Indonesia (Persero) Tbk PT
XMUN:BYRA
|
ID |
|
Vale SA
NYSE:VALE
|
BR |
|
F
|
Franklin Resources Inc
SWB:FRK
|
US |
|
R
|
Rakuten Bank Ltd
TSE:5838
|
JP |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
H
|
Hudbay Minerals Inc
NYSE:HBM
|
CA |
|
Grupo Aeroportuario del Centro Norte SAB De CV
F:G7A
|
MX |
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
Puma SE
XETRA:PUM
|
DE |
|
W
|
Westlake Corp
XMUN:UEO
|
US |
|
Everbright Securities Co Ltd
SSE:601788
|
CN |
Bankruptcy Probability
Inhibikase Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Inhibikase Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
307.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Inhibikase Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Inhibikase Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.